ACCELERON PHARMA INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 90 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-12-19: Reporting owner Kumar Ravindra; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-19: Reporting owner Kumar Ravindra; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-19: Reporting owner MCLAUGHLIN KEVIN F; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-18: Reporting owner Sherman Matthew L; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-12-19 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,985 0 owned after | $0.92 exercise price | 2014-12-19 | |
| 2014-12-19 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,825 7,300 owned after | $1.80 exercise price | 2014-12-19 | |
| 2014-12-19 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 110,751 owned after | $3.88 exercise price | 2014-12-19 | |
| 2014-12-18 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 32,000 owned after | $0.48 exercise price | 2014-12-19 | |
| 2014-12-17 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 36,240 owned after | $3.88 exercise price | 2014-12-19 | |
| 2014-12-17 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 35,500 owned after | $3.88 exercise price | 2014-12-19 | |
| 2014-12-12 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 3,500 owned after | $0.92 exercise price | 2014-12-16 | |
| 2014-12-11 | Nader Francois Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $41.48 exercise price | 2014-12-12 | |
| 2014-12-10 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 29,496 owned after | $5.08 exercise price | 2014-12-12 | |
| 2014-12-08 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 125,751 owned after | $3.88 exercise price | 2014-12-09 | |
| 2014-12-01 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 8,500 owned after | $5.88 exercise price | 2014-12-02 | |
| 2014-12-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,031 0 owned after | $0.92 exercise price | 2014-12-02 | |
| 2014-12-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,969 11,094 owned after | $1.80 exercise price | 2014-12-02 | |
| 2014-12-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 6,250 owned after | $5.08 exercise price | 2014-12-02 | |
| 2014-11-18 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,082 36,000 owned after | $0.48 exercise price | 2014-11-18 | |
| 2014-11-14 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 7,500 owned after | $0.92 exercise price | 2014-11-18 | |
| 2014-11-13 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 1,500 owned after | $5.88 exercise price | 2014-11-14 | |
| 2014-11-13 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 16,500 owned after | $5.28 exercise price | 2014-11-14 | |
| 2014-11-12 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,101 9,399 owned after | $5.88 exercise price | 2014-11-14 | |
| 2014-11-12 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,899 7,031 owned after | $7.12 exercise price | 2014-11-14 | |
| 2014-11-12 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 14,500 owned after | $5.88 exercise price | 2014-11-14 | |
| 2014-11-12 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,414 0 owned after | $1.80 exercise price | 2014-11-14 | |
| 2014-11-12 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,504 33,496 owned after | $5.08 exercise price | 2014-11-14 | |
| 2014-11-12 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 135,751 owned after | $3.88 exercise price | 2014-11-14 | |
| 2014-11-12 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,687 0 owned after | $0.92 exercise price | 2014-11-14 | |
| 2014-11-12 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −313 2,031 owned after | $0.92 exercise price | 2014-11-14 | |
| 2014-11-12 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 8,750 owned after | $5.08 exercise price | 2014-11-14 | |
| 2014-10-27 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 145,751 owned after | $3.88 exercise price | 2014-10-27 | |
| 2014-10-14 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 11,500 owned after | $0.92 exercise price | 2014-10-16 | |
| 2014-10-08 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,082 2,414 owned after | $1.80 exercise price | 2014-10-09 | |
| 2014-10-07 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 155,751 owned after | $3.88 exercise price | 2014-10-09 | |
| 2014-10-01 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 18,500 owned after | $5.88 exercise price | 2014-10-01 | |
| 2014-10-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,875 0 owned after | $0.40 exercise price | 2014-10-01 | |
| 2014-10-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,125 4,687 owned after | $0.92 exercise price | 2014-10-01 | |
| 2014-10-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 13,750 owned after | $5.08 exercise price | 2014-10-01 | |
| 2014-09-30 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 6,500 owned after | $5.88 exercise price | 2014-10-01 | |
| 2014-09-30 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 21,500 owned after | $5.28 exercise price | 2014-10-01 | |
| 2014-09-30 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,430 13,707 owned after | $5.28 exercise price | 2014-10-01 | |
| 2014-09-30 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,570 8,930 owned after | $7.12 exercise price | 2014-10-01 | |
| 2014-09-12 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 15,500 owned after | $0.92 exercise price | 2014-09-12 | |
| 2014-09-09 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,700 165,751 owned after | $3.88 exercise price | 2014-09-10 | |
| 2014-09-08 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,300 172,451 owned after | $3.88 exercise price | 2014-09-10 | |
| 2014-09-03 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 6,496 owned after | $1.80 exercise price | 2014-09-04 | |
| 2014-09-02 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4/A | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 20,500 owned after | $5.88 exercise price | 2014-12-02 | |
| 2014-09-02 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 8,000 owned after | $5.88 exercise price | 2014-09-04 | |
| 2014-09-02 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 18,750 owned after | $5.08 exercise price | 2014-09-04 | |
| 2014-09-02 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 1,875 owned after | $0.40 exercise price | 2014-09-04 | |
| 2014-08-25 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 37,500 owned after | $3.88 exercise price | 2014-08-26 | |
| 2014-08-14 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 182,751 owned after | $3.88 exercise price | 2014-08-15 | |
| 2014-08-14 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 175,751 owned after | $3.88 exercise price | 2014-08-15 | |
| 2014-08-14 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 17,500 owned after | $0.92 exercise price | 2014-08-15 | |
| 2014-08-14 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,137 9,873 owned after | $5.28 exercise price | 2014-08-15 | |
| 2014-08-14 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,863 17,137 owned after | $5.28 exercise price | 2014-08-15 | |
| 2014-08-14 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 10,000 owned after | $5.88 | 2014-08-15 | |
| 2014-08-14 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 4,375 owned after | $0.40 exercise price | 2014-08-15 | |
| 2014-08-14 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 26,250 owned after | $5.08 exercise price | 2014-08-15 | |
| 2014-08-14 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,684 40,081 owned after | $0.48 exercise price | 2014-08-15 | |
| 2014-08-14 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,316 10,496 owned after | $1.80 exercise price | 2014-08-15 | |
| 2014-08-12 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 14,812 owned after | $1.80 exercise price | 2014-08-13 | |
| 2014-07-30 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 46,500 owned after | $3.88 exercise price | 2014-08-01 | |
| 2014-07-23 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 22,812 owned after | $1.80 exercise price | 2014-07-25 | |
| 2014-07-14 | Kearney Terrence C Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $28.37 exercise price | 2014-07-16 | |
| 2014-07-14 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 19,500 owned after | $0.92 exercise price | 2014-07-16 | |
| 2014-07-14 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 13,010 owned after | $5.28 exercise price | 2014-07-16 | |
| 2014-07-09 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 41,765 owned after | $0.48 exercise price | 2014-07-11 | |
| 2014-07-07 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 192,751 owned after | $3.88 exercise price | 2014-07-09 | |
| 2014-07-07 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 185,751 owned after | $3.88 exercise price | 2014-07-09 | |
| 2014-07-01 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $34.05 exercise price | 2014-07-02 | |
| 2014-07-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 33,750 owned after | $5.08 exercise price | 2014-07-02 | |
| 2014-07-01 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 6,875 owned after | $0.40 exercise price | 2014-07-02 | |
| 2014-06-20 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 15,000 owned after | $5.88 exercise price | 2014-06-24 | |
| 2014-06-17 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 54,500 owned after | $3.88 exercise price | 2014-06-19 | |
| 2014-06-13 | Quisel John D Officer (VP General Counsel & Secretary) | 4 | Option to purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 21,500 owned after | $0.92 exercise price | 2014-06-17 | |
| 2014-06-13 | Quisel John D Officer (VP General Counsel & Secretary) | 4 | Option to purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,260 51,240 owned after | $3.88 exercise price | 2014-06-17 | |
| 2014-06-13 | Quisel John D Officer (VP General Counsel & Secretary) | 4 | Option to purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,740 16,010 owned after | $5.28 exercise price | 2014-06-17 | |
| 2014-06-11 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 47,765 owned after | $0.48 exercise price | 2014-06-13 | |
| 2014-06-09 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 202,751 owned after | $3.88 exercise price | 2014-06-11 | |
| 2014-06-09 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 195,751 owned after | $3.88 exercise price | 2014-06-11 | |
| 2014-06-02 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 41,250 owned after | $5.08 exercise price | 2014-06-04 | |
| 2014-06-02 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 9,375 owned after | $0.40 exercise price | 2014-06-04 | |
| 2014-05-28 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 53,765 owned after | $0.48 exercise price | 2014-05-30 | |
| 2014-05-19 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 20,000 owned after | $5.88 exercise price | 2014-05-21 | |
| 2014-05-19 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 11,875 owned after | $0.40 exercise price | 2014-05-21 | |
| 2014-05-19 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 48,750 owned after | $5.08 exercise price | 2014-05-21 | |
| 2014-05-19 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 212,751 owned after | $3.88 exercise price | 2014-05-21 | |
| 2014-05-19 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 205,751 owned after | $3.88 exercise price | 2014-05-21 | |
| 2014-05-19 | Quisel John D Officer (VP General Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 23,500 owned after | $0.92 exercise price | 2014-05-21 | |
| 2014-05-19 | Quisel John D Officer (VP General Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 55,500 owned after | $3.88 exercise price | 2014-05-21 | |
| 2014-04-22 | Quisel John D Officer (VP General Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 25,500 owned after | $0.92 exercise price | 2014-04-24 | |
| 2014-04-22 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +2,500 14,375 owned after | $0.40 exercise price | 2014-04-24 |